In this article, we are going to take a look at where Merck & Co. Inc. (NYSE ... Chief Market Strategist at New York Life Investments, emphasized that the fundamental picture remains cloudy ...

The site’s proximity to Merck’s existing facilities across neighbouring New Jersey and Pennsylvania will expand its nexus of talent and create broad and engaging opportunities for current and future ...

Merck & Co. will grow its U.S. manufacturing footprint ... The facility’s products will include biologic drugs and a new, easier-to-use version of Keytruda, the company’s blockbuster cancer ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Davis, chairman and chief executive officer, Merck. Establishing a biologics center of excellence The new facility ... Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA This ...

(Reuters) -U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs. The new ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.

April 29 (Reuters) - U.S. drugmaker Merck (MRK.N), opens new tab said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with ...

At 72 years of age, Cardinal Joseph W. Tobin, the progressive Archbishop of Newark, is one of the ten cardinals from the United States that will have a vote at the conclave to elect a new pope ...